A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection
Dynamics of Hepatitis C Infection in Subjects With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Receiving Highly Active Antiretroviral Therapy (HAART)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Contacts and Locations
Study Locations
-
-
-
San Juan, Puerto Rico, 009365067
- Univ of Puerto Rico
-
-
-
-
California
-
Los Angeles, California, United States, 900331079
- Univ of Southern California / LA County USC Med Ctr
-
Menlo Park, California, United States, 94025
- Willow Clinic
-
San Diego, California, United States, 921036325
- Univ of California / San Diego Treatment Ctr
-
San Francisco, California, United States, 941102859
- San Francisco Gen Hosp
-
San Rafael, California, United States, 94903
- Marin County Specialty Clinic
-
Stanford, California, United States, 943055107
- San Mateo AIDS Program / Stanford Univ
-
Stanford, California, United States, 943055107
- Stanford Univ Med Ctr
-
Torrance, California, United States, 90502
- Harbor UCLA Med Ctr
-
-
Colorado
-
Denver, Colorado, United States, 80262
- Univ of Colorado Health Sciences Ctr
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20059
- Howard Univ
-
-
Florida
-
Miami, Florida, United States, 331361013
- Univ of Miami School of Medicine
-
-
Georgia
-
Atlanta, Georgia, United States, 30308
- Emory Univ
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96816
- Univ of Hawaii
-
Honolulu, Hawaii, United States, 96816
- Queens Med Ctr
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Univ Med School
-
Chicago, Illinois, United States, 60612
- Rush Presbyterian - Saint Luke's Med Ctr
-
Chicago, Illinois, United States, 60612
- Cook County Hosp
-
Chicago, Illinois, United States, 60640
- Louis A Weiss Memorial Hosp
-
-
Indiana
-
Indianapolis, Indiana, United States, 462025250
- Indiana Univ Hosp
-
Indianapolis, Indiana, United States, 46202
- Division of Inf Diseases/ Indiana Univ Hosp
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Tulane Univ School of Medicine
-
New Orleans, Louisiana, United States, 70112
- Charity Hosp / Tulane Univ Med School
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hosp
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Harvard (Massachusetts Gen Hosp)
-
Boston, Massachusetts, United States, 02118
- Boston Med Ctr
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Univ of Minnesota
-
-
Missouri
-
St Louis, Missouri, United States, 63112
- St Louis Regional Hosp / St Louis Regional Med Ctr
-
-
New York
-
Buffalo, New York, United States, 14215
- SUNY / Erie County Med Ctr at Buffalo
-
New York, New York, United States, 10003
- Beth Israel Med Ctr
-
New York, New York, United States, 10021
- Cornell Univ Med Ctr
-
New York, New York, United States, 10016
- Bellevue Hosp / New York Univ Med Ctr
-
New York, New York, United States, 10021
- Chelsea Ctr
-
New York, New York, United States, 10032
- Columbia Presbyterian Med Ctr
-
Rochester, New York, United States, 14642
- Univ of Rochester Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 275997215
- Univ of North Carolina
-
-
Ohio
-
Cincinnati, Ohio, United States, 452670405
- Univ of Cincinnati
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve Univ
-
Columbus, Ohio, United States, 432101228
- Ohio State Univ Hosp Clinic
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Univ of Pennsylvania at Philadelphia
-
-
South Carolina
-
West Columbia, South Carolina, United States, 29169
- Julio Arroyo
-
-
Texas
-
Galveston, Texas, United States, 775550435
- Univ of Texas Galveston
-
-
Washington
-
Seattle, Washington, United States, 98104
- Univ of Washington
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Patients may be eligible for this study if they:
- Are HIV-positive and have Hepatitis C.
- Have an HIV blood level of at least 2,500 copies/ml 30 days before study entry.
- Are co-enrolled in an active adult AIDS clinical trial using anti-HIV treatment.
- Are at least 13 years of age (parent or guardian consent required if under 18).
Exclusion Criteria
Patients will not be eligible for this study if they:
- Have liver disease.
- Have cancer requiring chemotherapy.
- Have Hepatitis B.
- Abuse alcohol and/or drugs.
- Have received certain antiretroviral (anti-HIV) drugs in the past.
Study Plan
How is the study designed?
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Raymond Chung
- Study Chair: Cecilia Shikuma
Publications and helpful links
Study record dates
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- RNA Virus Infections
- Virus Diseases
- Blood-Borne Infections
- Disease Attributes
- Liver Diseases
- Flaviviridae Infections
- Hepatitis, Viral, Human
- Enterovirus Infections
- Picornaviridae Infections
- Infections
- Communicable Diseases
- Hepatitis
- Hepatitis A
- Hepatitis C
Other Study ID Numbers
Other Study ID Numbers
- ACTG 383
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.